drug

Active 1-Hertz Repetitive transcranial magnetic stimulation

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by Yale University
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
DEVICE

Indications

Trials

1
Transcranial Magnetic Stimulation for "Voices"
NCT00308997Phase 2Completed

KOLs & investigators

1
Ralph E. Hoffman, MD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Yale University
company
trial
Transcranial Magnetic Stimulation for "Voices"
PHASE2
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Hallucinations
indication
Hallucinations
indication
KOL
Ralph E. Hoffman, MD
KOL score —
person